Benzimidazole
Benznidazole (benzimidazole) is a small molecule pharmaceutical. Benzimidazole was first approved as Benznidazole on 2017-08-29. It is known to target fMet-Leu-Phe receptor.
| Trade Name | Benznidazole |
|---|---|
| Common Name | Benzimidazole |
| Indication | |
| Drug Class |
